Astrazeneca (AZN)

 

Latest News

AstraZeneca buoyed by encouraging start

AstraZeneca has reported an encouraging start to the year with first quarter core operating profits rising to $1,667m - up 5%...

AstraZeneca: Q1 2017 Results

RNS Number: 4739D AstraZeneca PLC 27 April 2017 AstraZeneca PLC 27 April 2017 07:00 Q1 2017 Results An encouraging start as the pipeline newsflow continued in a potentially defining year Financial Summary $m % change Actual 1 CER 2 Total Revenue 5,405 (12) (10) Product Sales 4,843 (13) (12) Externalisation Revenue 562 2 3 Reported Operating Profit 917 (12) ...

AZN receives full approval of Tagrisso from EC

AstraZeneca has announced that the European Commission (EC) has granted full marketing authorisation for Tagrisso (o...

TAGRISSO RECEIVES FULL APPROVAL IN THE EU

RNS Number: 2753D AstraZeneca PLC 25 April 2017 25 April 2017 13:30 BST TAGRISSO RECEIVES FULL APPROVAL IN THE EU Full approval follows Tagrisso's expedited Conditional Marketing Authorisation as first-in-class medicine for patients with locally-advanced or metastatic EGFR T790M mutation-positive non-small cell lung cancer Tagrisso is a potentia...

All News

DateHeadlineSource
27-04-17AstraZeneca buoyed by encouraging start StockMarketWire
27-04-17AstraZeneca: Q1 2017 ResultsRNS
25-04-17AZN receives full approval of Tagrisso from ECStockMarketWire
25-04-17TAGRISSO RECEIVES FULL APPROVAL IN THE EURNS
24-04-17 The 10 shares owned by 70% of UK equity income fundsMoneywise
21-04-17Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
12-04-17Notification of Major Interest in SharesRNS
10-04-17Broker views: Pharma, software and energy consultingStockMarketWire
10-04-17Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
07-04-17Broker Forecast - HSBC issues a broker note on AstraZeneca PLCStockMarketWire
03-04-17Total Voting RightsRNS
31-03-17Shell pushes FTSE lower as oil prices slipStockMarketWire
31-03-17Miners drag on FTSE as commodity prices fall StockMarketWire
31-03-17AZ lung cancer drug gets US approval StockMarketWire
31-03-17Tagrisso (osimertinib) receives FDA full approvalRNS
31-03-17AZ COMPLETES AGREEMENT WITH TERSERA THERAPEUTICSRNS
28-03-17Director/PDMR ShareholdingRNS
27-03-17Director/PDMR ShareholdingRNS
27-03-1712 changes to this Top Picks portfolioInteractive Investor
23-03-17Broker Forecast - Societe Generale issues a broker note on AstraZeneca PLCStockMarketWire
21-03-17Why Lloyds Banking is among top share tips in EuropeInteractive Investor
20-03-17Chart of the week: How to play this successful tradeInteractive Investor
20-03-17Broker Forecast - Berenberg issues a broker note on AstraZeneca PLCStockMarketWire
17-03-17FTSE drifts sideways Friday rates-led volatilityStockMarketWire
17-03-17FDA issues CRL for AZ's hyperkalaemia drug StockMarketWire
17-03-17US FDA issues CRL for ZS-9 in hyperkalaemiaRNS
16-03-17AZN schedules AGMStockMarketWire
16-03-17Notice of AGMRNS
15-03-17FTSE rises on banks and mining stocksStockMarketWire
15-03-17Miners dominate FTSE on upbeat Chinese dataStockMarketWire
15-03-17AZ pleased with ovarian cancer drug test results StockMarketWire
15-03-17LYNPARZA PFS IN BRCA OVARIAN MAINTENANCE THERAPYRNS
13-03-17Hutchison China MediTech shares tipped to hit record highInteractive Investor
13-03-17Chart of the week: A big money trade Interactive Investor
09-03-17Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
08-03-17Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLCStockMarketWire
08-03-17Filing of Form 20-F with SECRNS
07-03-17Annual Financial ReportRNS
06-03-17Directorate ChangeRNS
03-03-17FTSE flat ahead of Yellen speechStockMarketWire

RSS feeds

  • Editorial news feed for LSE:AZN Editorial
  • Regulatory news feed for LSE:AZN Regulatory